PAPER Abdelsalam SM, Matter AH, El-Hariri HM, Assaf AH, Khater MS, Tawfik HM

Adaptation and validation of the modified Egyptian Arabic version of Addenbrooke's Cognitive Examination III (VI-ACE-III) for assessing cognitive impairment in visually impaired elderly.

BMC Geriatr. 2025 Mar 4;25(1):145. PubMed.

PAPER Zhu Y, Wang A, Zhou Y, Yuan S, Ji Y, Hu W, Alzheimer’s disease Neuroimaging Initiative

Altered spatiotemporal consistency and their genetic mechanisms in mild cognitive impairment: a combined neuroimaging and transcriptome study.

Cereb Cortex. 2025 Feb 5;35(2) PubMed.

PAPER Gonzales MM, Fernandez R, Kremen S, Tan ZS, Werry AE, Jian X, Hart J, Royall D, Maestre G, Espinoza S, Seshadri S, Gelfond J, Wang CP

Predictors of bi-directional transitions from mild cognitive impairment in a diverse cohort.

J Gerontol A Biol Sci Med Sci. 2025 Feb 27; Epub 2025 Feb 27 PubMed.

PAPER de Rezende VL, de Aguiar da Costa M, Martins CD, Mathias K, Gonçalves CL, Barichello T, Petronilho F

Systemic Rejuvenating Interventions: Perspectives on Neuroinflammation and Blood-Brain Barrier Integrity.

Neurochem Res. 2025 Mar 4;50(2):112. PubMed.

PAPER Zhong YY, Deng JZ, Wang Q, Chen L, Yang ZH, Zhang YM, Zhou LY, Li YR, Wu JQ, Wang XQ

Development of novel melatonin-isatin hybrids as multifunctional agents for Alzheimer's disease.

Mol Divers. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Azargoonjahromi A, Alzheimer’s Disease Neuroimaging Initiative

Plasma tryptophan levels are linked to hippocampal integrity and cognitive function in individuals with mild cognitive impairment.

Brain Imaging Behav. 2025 Mar 4; Epub 2025 Mar 4 PubMed.

PAPER Kumar H, Datusalia AK, Kumar A, Khatik GL

Network pharmacology exploring the mechanistic role of indirubin phytoconstituent from Indigo naturalis targeting GSK-3β in Alzheimer's disease.

J Biomol Struct Dyn. 2025 Mar 4;:1-14. Epub 2025 Mar 4 PubMed.

PAPER Maazouzi M, Rasheed M, Mbarek L, Wang X, Liang J, Ma H, Chen Z, Deng Y

Exploring Non-Coding RNA Regulation of the Blood-Brain Barrier in Neurodegenerative Diseases: A Systematic Review.

J Neurochem. 2025 Mar;169(3):e70031. PubMed.

PAPER Arendt P, Römpler K, Brix B, Borchardt-Lohölter V, Busse M, Busse S

Corrigendum: Differentiation of Alzheimer's disease from other neurodegenerative disorders using chemiluminescence immunoassays measuring cerebrospinal fluid biomarkers.

Front Dement. 2025;4:1568275. Epub 2025 Feb 17 PubMed. Corrected paper.

PAPER Shimokawa H, Akishita M, Ihara M, Teramukai S, Ishiki A, Nagai Y, Fukushima M

Pivotal trial of low-intensity pulsed ultrasound therapy for early Alzheimer's disease: Rationale and design.

J Alzheimers Dis Rep. 2025;9:25424823241312108. Epub 2025 Jan 13 PubMed.

PAPER Simpson AJ, Wyman-Chick KA, Daniel MS

Neuropsychological and clinical indicators of Lewy body and Alzheimer's pathology.

J Alzheimers Dis Rep. 2025;9:25424823241304386. Epub 2025 Jan 13 PubMed.

PAPER Dos Santos Ono RM, Dos Santos Moreira NC, Carvalho I, Passos GA, Sakamoto-Hojo ET

Novel donepezil-tacrine hybrid (TAHB3) induces neurodifferentiation, neuroprotective effects, and activates the PI3K/AKT pathway on PC12 cells.

J Alzheimers Dis Rep. 2025;9:25424823241309268. Epub 2025 Jan 13 PubMed.

PAPER Ott FW, Sichler ME, Bouter C, Enayati M, Wiltfang J, Bayer TA, Beindorff N, Löw MJ, Bouter Y

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice.

J Alzheimers Dis Rep. 2025;9:25424823241306770. Epub 2025 Feb 27 PubMed.

PAPER Cui L, Wan Y, Lu Y, Meng M, Zhang N

Sleep disturbances and their correlation with memory impairment in patients with Alzheimer's disease and amnestic mild cognitive impairment.

J Alzheimers Dis Rep. 2025;9:25424823241309063. Epub 2025 Jan 13 PubMed.

PAPER Mohamed Amine J, Mourad M, Alzheimer's Disease Neuroimaging Initiative (ADNI)

Alzheimer's disease classification by supervised and intelligent techniques.

J Alzheimers Dis Rep. 2025;9:25424823241311838. Epub 2025 Jan 13 PubMed.